Treatment of Anastomotic Leakage After Rectal Cancer Resection
TENTACLE:R
Treatment of AnastomotiC Leakage After Rectal Cancer Resection. TENTACLE Rectum Study
1 other identifier
observational
1,246
0 countries
N/A
Brief Summary
The TENTACLE: Rectum study is a multinational retrospective cohort study that includes patients with anastomotic leakage after rectal cancer resection. The study aims to develop an anastomotic leakage severity score and to evaluate the efficacy of different treatments of anastomotic leakage.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2020
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 14, 2019
CompletedFirst Posted
Study publicly available on registry
October 16, 2019
CompletedStudy Start
First participant enrolled
April 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2021
CompletedOctober 21, 2019
October 1, 2019
9 months
October 14, 2019
October 17, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
1-year stomafree survival
Survival of the patient and absence of a stoma
1 year
Secondary Outcomes (2)
ICU length of stay
1 year
1 year mortality
1 year
Other Outcomes (8)
Comprehensive complications index
1 year
Readmission rate
1 year
Reintervention rate
1 year
- +5 more other outcomes
Interventions
Investigated interventions comprise conservative, radiological, endoscopic and surgical (including stoma formation) interventions
Eligibility Criteria
All consecutive adult rectal cancer patients who have been operated between January 2014-December 2018 will be retrospectively analyzed and evaluated for an anastomotic leakage. All patients with an anastomotic leakage diagnosed within one year from primary surgery are suitable for inclusion.
You may qualify if:
- Aged 18 years or older;
- Cancer located in the rectum, defined according to the international definition of the rectum consensus \[D'Souza 2019\];
- Rectal cancer resection with primary anastomosis (with or without diverting loop ileostomy) for either primary cancer, completion after local excision or salvage resection for regrowth after watch \& wait or local excision;
- Postoperative anastomotic leakage according to the following definition: "a breach in a surgical join between two hollow viscera, with or without active leak of luminal contents" \[Peel 1991\].
You may not qualify if:
- Rectal resection for benign disease;
- Rectal resection for recurrent rectal cancer after previous low anterior resection or other primary malignancies;
- Multivisceral resection (lateral lymph node dissection can be included)
- Emergency resection;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hans de Wilt, MD, PhD
Radboud University Medical Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 14, 2019
First Posted
October 16, 2019
Study Start
April 1, 2020
Primary Completion
December 31, 2020
Study Completion
September 30, 2021
Last Updated
October 21, 2019
Record last verified: 2019-10